We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 77

Comments invited on FDA's proposed rules for animal foodfeed manufacturing practices
  • Faegre Baker Daniels LLP
  • USA
  • October 28 2013

Last Friday, the U.S. Food and Drug Administration (FDA) announced the release of a long-awaited proposed rule required by Section 103 of the Food


What reopening of the government means for medical device stakeholders
  • Faegre Baker Daniels LLP
  • USA
  • October 18 2013

Business is back to normal or close to normal for the Food and Drug Administration's Center for Devices and Radiological Health


FDA holds public meeting on FSMA import safety rules
  • Faegre Baker Daniels LLP
  • USA
  • October 7 2013

On September 19-20, 2013, the U.S. Food and Drug Administration (FDA) conducted a public meeting on Proposed Rules published in July to implement


Effects of government shutdown and Farm Bill expiration on food and agriculture industry
  • Faegre Baker Daniels LLP
  • USA
  • October 7 2013

The shutdown of the federal government for the first time since 1996, initiated at 12:00 a.m. On Tuesday, October 1, 2013, by the expiration of FY


Health and biosciences: the lowdown on the showdown
  • Faegre Baker Daniels LLP
  • USA
  • October 3 2013

As the shutdown of the federal government continues and hopes for a near-term resolution diminish, clients particularly those in the health and


FDA continues FSMA implementation with release of two key proposed rules
  • Faegre Baker Daniels LLP
  • USA
  • July 26 2013

On July 26, 2013, FDA released two key Proposed Rules as part of the implementation of the Food Safety Modernization Act (FSMA), signed into law in


Supreme Court decides Mutual Pharmaceutical Co. v. Bartlett
  • Faegre Baker Daniels LLP
  • USA
  • June 24 2013

On June 24, 2013, the Supreme Court of the United States decided Mutual Pharmaceutical Co. v. Bartlett, No. 12-142, holding that state-law


FDA extends comment period for proposed food safety rules on preventive controls and produce safety
  • Faegre Baker Daniels LLP
  • USA
  • April 24 2013

Today, the U.S. Food and Drug Administration (FDA) announced that they would extend for 120 days the comment period for two proposed rules that were


FDA public comment sessions: engaging the industry
  • Faegre Baker Daniels LLP
  • USA
  • March 20 2013

The U.S. Food and Drug Administration (FDA) recently concluded the second of three public meetings being held to solicit public comment on two


Health care reform FAQs address women’s preventive services
  • Faegre Baker Daniels LLP
  • USA
  • March 7 2013

As we discussed in an earlier post, non-grandfathered group health plans must cover certain women's preventive services without cost-sharing for plan